Last mentioned: Mar 12, 2026
Expected Rollout
Full commercial availability of the next-generation uAI platform in the EU market.
Clinical Data Release
Presentation of multi-center validation studies for uAI oncology tools.
ECR 2026 Presentation
United Imaging Intelligence unveils its 'AI at Scale' strategy in Vienna.
ECR 2026 Opening
UII launches its 'Validating, Expanding, and Applying' theme in Vienna.
European Market Push
Expected increase in partnerships with European hospital networks following ECR showcase.
Portfolio Expansion
UII expands uAI platform to include advanced neuro and oncology suites.
Global Expansion
UII secures major CE and FDA clearances for core uAI modules.
United Imaging Intelligence (UII) showcased its latest medical AI advancements at the European Congress of Radiology (ECR) 2026, focusing on clinical validation and large-scale deployment. The company's strategy emphasizes integrating AI across multiple imaging modalities to streamline diagnostic workflows and improve patient outcomes.
United Imaging Intelligence (UII) showcased its latest AI-driven radiology solutions at the European Congress of Radiology (ECR) 2026, focusing on clinical validation and scalable deployment. The company's presentation highlighted a shift from experimental AI to integrated, full-stack clinical workflows.
United Imaging Intelligence (UII) unveiled a major expansion of its AI portfolio at the European Congress of Radiology (ECR) 2026, emphasizing clinical validation and large-scale deployment. The company's latest 'uAI' solutions aim to transition radiology AI from experimental tools to essential clinical infrastructure.